Skip to main content
NCBI home page
CMAJ : Canadian Medical Association Journal logoLink to CMAJ : Canadian Medical Association Journal
. 1999 Nov 30;161(11):1403–1408.

Use of beta-blocker therapy in older patients after acute myocardial infarction in Ontario.

P A Rochon 1, G M Anderson 1, J V Tu 1, J P Clark 1, J H Gurwitz 1, J P Szalai 1, P Lau 1
PMCID: PMC1230828  PMID: 10906894

Abstract

BACKGROUND: Despite its proven efficacy, beta-blocker therapy remains underused in elderly patients after myocardial infarction (MI). The objectives of this study were to identify undertreated groups of seniors and to determine whether older and frailer patients are being selectively dispensed low-dose beta-blocker therapy. METHODS: From a comprehensive hospital discharge database, all people aged 66 years or more in Ontario who survived an acute MI between April 1993 and March 1995 were identified and classified into those who did not receive beta-blocker therapy and those dispensed low, standard or high doses of this agent. Logistic regression models were used to study the effect of age, sex, comorbidity, potential contraindications to beta-blocker therapy and residence in a long-term-care facility on the odds of not being dispensed a beta-blocker. Among beta-blocker users, the odds of being dispensed low relative to standard or high doses of this agent were evaluated. RESULTS: Of the 15,542 patients, 7549 (48.6%) were not dispensed a beta-blocker. Patients 85 years of age or more were at greater risk of not receiving beta-blocker therapy (adjusted odds ratio [OR] 2.8, 95% confidence interval [CI] 2.5-3.2) than were those 66 to 74 years. Having a Charlson comorbidity index of 3 or greater was associated with an increased risk of not receiving beta-blocker therapy (adjusted OR 1.5, 95% CI 1.3-1.8) compared with having lower comorbidity scores. Patients who resided in a long-term-care facility were at increased risk of not being prescribed beta-blocker therapy (adjusted OR 2.6, 95% CI 2.0-3.4). Among the 5453 patients with no identifiable contraindication to beta-blocker therapy, women were significantly less likely than men to receive this agent (p = 0.005). Of the 6074 patients who received beta-blockers, 2248 (37.0%) were dispensed low-dose therapy. Patients aged 85 years or more had an increased risk of being dispensed low-dose therapy (adjusted OR 1.6, 95% CI 1.3-2.0) compared with those aged 66 to 74 years. Compared with those who had the lowest comorbidity scores, patients with the highest comorbidity scores were more likely to be dispensed low-dose beta-blocker therapy (adjusted OR 1.3, 95% CI 1.0-1.8). INTERPRETATION: Almost half of Ontario patients aged 66 or more who survived an MI, particularly those who were older or frailer, did not receive beta-blocker therapy. Among those dispensed beta-blocker therapy, older and frailer patients were more frequently dispensed low-dose therapy.

Full Text

The Full Text of this article is available as a PDF (269.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aronow W. S. Prevalence of use of beta blockers and of calcium channel blockers in older patients with prior myocardial infarction at the time of admission to a nursing home. J Am Geriatr Soc. 1996 Sep;44(9):1075–1077. doi: 10.1111/j.1532-5415.1996.tb02941.x. [DOI] [PubMed] [Google Scholar]
  2. Charlson M. E., Pompei P., Ales K. L., MacKenzie C. R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–383. doi: 10.1016/0021-9681(87)90171-8. [DOI] [PubMed] [Google Scholar]
  3. Deyo R. A., Cherkin D. C., Ciol M. A. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992 Jun;45(6):613–619. doi: 10.1016/0895-4356(92)90133-8. [DOI] [PubMed] [Google Scholar]
  4. Fallen E. L., Cairns J., Dafoe W., Frasure-Smith N., Genest J., Jr, Massel D., Peretz D., Tremblay G. J., Williams W. L. Management of the postmyocardial infarction patient: a consensus report--revision of 1991 CCS guidelines. Can J Cardiol. 1995 Jun;11(6):477–486. [PubMed] [Google Scholar]
  5. Gottlieb S. S., McCarter R. J., Vogel R. A. Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction. N Engl J Med. 1998 Aug 20;339(8):489–497. doi: 10.1056/NEJM199808203390801. [DOI] [PubMed] [Google Scholar]
  6. Krumholz H. M., Radford M. J., Wang Y., Chen J., Heiat A., Marciniak T. A. National use and effectiveness of beta-blockers for the treatment of elderly patients after acute myocardial infarction: National Cooperative Cardiovascular Project. JAMA. 1998 Aug 19;280(7):623–629. doi: 10.1001/jama.280.7.623. [DOI] [PubMed] [Google Scholar]
  7. Lazarou J., Pomeranz B. H., Corey P. N. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA. 1998 Apr 15;279(15):1200–1205. doi: 10.1001/jama.279.15.1200. [DOI] [PubMed] [Google Scholar]
  8. McClellan M., McNeil B. J., Newhouse J. P. Does more intensive treatment of acute myocardial infarction in the elderly reduce mortality? Analysis using instrumental variables. JAMA. 1994 Sep 21;272(11):859–866. [PubMed] [Google Scholar]
  9. Normand S. T., Glickman M. E., Sharma R. G., McNeil B. J. Using admission characteristics to predict short-term mortality from myocardial infarction in elderly patients. Results from the Cooperative Cardiovascular Project. JAMA. 1996 May 1;275(17):1322–1328. [PubMed] [Google Scholar]
  10. Pashos C. L., Newhouse J. P., McNeil B. J. Temporal changes in the care and outcomes of elderly patients with acute myocardial infarction, 1987 through 1990. JAMA. 1993 Oct 20;270(15):1832–1836. [PubMed] [Google Scholar]
  11. Rochon P. A., Anderson G. M., Tu J. V., Gurwitz J. H., Clark J. P., Shear N. H., Lau P. Age- and gender-related use of low-dose drug therapy: the need to manufacture low-dose therapy and evaluate the minimum effective dose. J Am Geriatr Soc. 1999 Aug;47(8):954–959. doi: 10.1111/j.1532-5415.1999.tb01290.x. [DOI] [PubMed] [Google Scholar]
  12. Rochon P. A., Fortin P. R., Dear K. B., Minaker K. L., Chalmers T. C. Reporting of age data in clinical trials of arthritis. Deficiencies and solutions. Arch Intern Med. 1993 Jan 25;153(2):243–248. [PubMed] [Google Scholar]
  13. Ryan T. J., Anderson J. L., Antman E. M., Braniff B. A., Brooks N. H., Califf R. M., Hillis L. D., Hiratzka L. F., Rapaport E., Riegel B. J. ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). J Am Coll Cardiol. 1996 Nov 1;28(5):1328–1428. doi: 10.1016/s0735-1097(96)00392-0. [DOI] [PubMed] [Google Scholar]
  14. Sherman S. S. Gender, health, and responsible research. Clin Geriatr Med. 1993 Feb;9(1):261–269. [PubMed] [Google Scholar]
  15. Soumerai S. B., McLaughlin T. J., Spiegelman D., Hertzmark E., Thibault G., Goldman L. Adverse outcomes of underuse of beta-blockers in elderly survivors of acute myocardial infarction. JAMA. 1997 Jan 8;277(2):115–121. [PubMed] [Google Scholar]
  16. Udvarhelyi I. S., Gatsonis C., Epstein A. M., Pashos C. L., Newhouse J. P., McNeil B. J. Acute myocardial infarction in the Medicare population. Process of care and clinical outcomes. JAMA. 1992 Nov 11;268(18):2530–2536. [PubMed] [Google Scholar]
  17. Wenger N. K. Coronary heart disease: an older woman's major health risk. BMJ. 1997 Oct 25;315(7115):1085–1090. doi: 10.1136/bmj.315.7115.1085. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Wenger N. K. Exclusion of the elderly and women from coronary trials. Is their quality of care compromised? JAMA. 1992 Sep 16;268(11):1460–1461. [PubMed] [Google Scholar]
  19. Wenger N. K., Speroff L., Packard B. Cardiovascular health and disease in women. N Engl J Med. 1993 Jul 22;329(4):247–256. doi: 10.1056/NEJM199307223290406. [DOI] [PubMed] [Google Scholar]
  20. Wilcox R. G., Roland J. M., Banks D. C., Hampton J. R., Mitchell J. R. Randomised trial comparing propranolol with atenolol in immediate treatment of suspected myocardial infarction. Br Med J. 1980 Mar 29;280(6218):885–888. doi: 10.1136/bmj.280.6218.885. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from CMAJ: Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES